Simplify Asset Management »

Lenz Therapeutics shares owned by Simplify Asset Management

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Simplify Asset Management from 13F filings

Historical chart of Simplify Asset Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Simplify Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Simplify Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $280k 18k 16.00

More positions owned by Simplify Asset Management

Simplify Exchange Traded Fun Government Money (SBIL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Simplify Exchange Traded Fun Us Eqt Pls Upsid (SPUC)
Simplify Exchange Traded Fun Multi Qis Altern (QIS)
Simplify Exchange Traded Fun Natl Muni Bd Etf (NMB)
Simplify Exchange Traded Fun Aggregate Bond E (AGGH)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Simplify Exchange Traded Fun Next Intangible (NXTI)
Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Regeneron Pharmaceuticals (REGN)
Amgen (AMGN)
Align Technology (ALGN)

View all positions for Simplify Asset Management

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
UBS Group
BlackRock
Vanguard Group
Franklin Resources
72 Investment Holdings
Tang Capital Management
Adage Capital Partners GP
Intrinsic Edge Capital Management
State Street Corporation
CAM Group Holding A/S
Squarepoint Ops
Standard Life Aberdeen

View all funds holding Lenz Therapeutics